Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof

Details for Australian Patent Application No. 2003242616 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Glombik, Heiner; Schaefer, HansLudwig; Frick, Wendelin; Kramer, Werner; Jaehne, Gerhard; Flohr, Stefanie; Lindenschmidt, Andreas; Heuer, Hubert

Agent Watermark

Pub. Number AU-B-2003242616

PCT Number PCT/EP03/05815

PCT Pub. Number WO2004/000804

Priority 102 27 506.8 19.06.02 DE

Filing date 4 June 2003

Wipo publication date 6 January 2004

Acceptance publication date 11 December 2008

International Classifications

C07D 205/08 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/195 (2006.01)

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5377 (2006.01)

A61K 31/64 (2006.01) - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 102 27 506.8 19.06.02 DE

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003242616

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

11 December 2008 Application Accepted

  Published as AU-B-2003242616

9 April 2009 Standard Patent Sealed

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003242617-POLYURETHANE ELASTOMER ADHESIVELY CONNECTED TO POLYTETRAFLUORETHYLENE AND AN ELASTIC BEARING CONTAINING ONE SUCH POLYURETHANE ELASTOMER

2003242615-Hazard navigation light for wind turbines